dilazep has been researched along with Hypertrophy, Left Ventricular in 1 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We measured serum cardiac troponin T levels by the Elecsys troponin T assay and randomized 40 hemodialysis patients with left ventricular hypertrophy (LVH) into two treatment groups: a dilazep dihydrochloride group (300 mg/day, n = 20) and a placebo group (n = 20)." | 5.10 | Effect of dilazep dihydrochloride on serum cardiac troponin T levels in hemodialysis patients. ( Ebihara, I; Koide, H; Nakamura, T; Osada, S; Shimada, N; Takahashi, Y; Tanaka, A; Ugai, K; Ushiyama, C, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, T | 1 |
| Ushiyama, C | 1 |
| Osada, S | 1 |
| Ugai, K | 1 |
| Takahashi, Y | 1 |
| Tanaka, A | 1 |
| Shimada, N | 1 |
| Ebihara, I | 1 |
| Koide, H | 1 |
1 trial available for dilazep and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Effect of dilazep dihydrochloride on serum cardiac troponin T levels in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Dilazep; Female; Humans; Hypertrophy, Left Ventricular; Male; Middle | 2002 |